Connect with us

The Guardians of Democracy

The Guardians of Democracy

Trump Lashes Out After Pelosi Calls Him ‘Morbidly Obese,’ Says She Has ‘Mental Problems’


Trump Lashes Out After Pelosi Calls Him ‘Morbidly Obese,’ Says She Has ‘Mental Problems’

Speaker Nancy Pelosi (D-Calif.} on Monday warned President Donald Trump not to take hydroxychloroquine, saying that health experts have warned about its effects and that it could be harmful to the president because he’s “morbidly obese.”

“As far as the president is concerned, he’s our president and I would rather he not be taking something that has not been approved by the scientists, especially in his age group and in his, shall we say, weight group, morbidly obese, they say. So, I think it’s not a good idea,” Pelosi said in an interview with Anderson Cooper on CNN.

On Tuesday, Trump was asked by reporters whether he had a reaction to the speaker’s remarks.

“I don’t,” he said. “I don’t respond to her. I think she’s a waste of time.”

A few minutes later, Trump said, “Pelosi is a sick woman. She’s got a lot of problems — a lot of mental problems.”

Pelosi’s comment came after Trump revealed that he had started taking the drug after consulting with the White House physician.

“A lot of good things have come out about the hydroxy. A lot of good things have come out. You’d be surprised at how many people are taking it, especially the front-line workers — before you catch it,” Trump said at the White House. “I happen to be taking it. … I’m taking it — hydroxychloroquine — right now.”

On Tuesday, Trump told reporters on Capitol Hill, “I think it gives you an additional level of safety, but you can ask many doctors are in favor of it. Many frontline workers won’t go there unless they have the hydroxy. And so again, this is an individual decision to make, but it’s had a great reputation. And if it was somebody else other than me, people would say, ‘Gee, isn’t that smart?'”

The FDA issued a warning last month that cautioned against the use of the medicine outside of a hospital setting or a clinical trial due to risk of heart rhythm problems.


More in NEWS

To Top